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Abstract
Background: Findings are compared on geographic variation of incident and late-stage cancers
across Connecticut using different areal units for analysis.
Results: Few differences in results were found for analyses across areal units. Global clustering of
incident prostate and breast cancer cases was apparent regardless of the level of geography used.
The test for local clustering found approximately the same locales, populations at risk and
estimated effects. However, some discrepancies were uncovered.
Conclusion: In the absence of conditions calling for surveillance of small area cancer clusters ('hot
spots'), the rationale for accepting the burdens of preparing data at levels of geography finer than
the census tract may not be compelling.
Background
The geographic study of cancer patterns can be an impor-
tant tool in disease control and prevention [1], as well as
a resource for generating hypotheses about pathogenesis
[2]. Unfortunately, there is little practical guidance availa-
ble as to whether or how to select an 'ideal' level of geog-
raphy for surveillance of events with distinctive spatial
autocorrelations [3]. Designating the geo-spatial locations
of health events (i.e., 'geocoding') so as to be accurate
(within acceptable error), precise (to a desired areal unit
of analysis) and 'fit for use' (applicable to other available
data) [4] can be vexing, even for those with great skill and
experience [4-12]. On the one hand, small areal units con-
taining few at-risk subjects will yield less reliable rates
than larger units, whereas on the other hand, large areal
units have potential to blur meaningful variation occur-
ring within locales. Communicating and interpreting
results that disentangle underlying risks from methodo-
logical artifact is important for public health workers and
epidemiologists alike.
Procedures for spatial analyses of suspected cancer 'hot
spots' [13] may be unnecessary and even inappropriate
[14] regarding studies of rate variation across large areas
[15], as well as those intended to evaluate resource alloca-
tions [16,17]. At the same time, concerns to protect confi-
dentiality of geographically referenced health data by
those entrusted to collect and manage surveillance data
may effectively eliminate some options for analysis. While
the underpinnings of the 'modifiable areal unit problem
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(MAUP)' have been well described [18,19], there is nei-
ther guidance to effectively deal with the problem nor few
real examples of whether or how differing aggregation
units affect actual results. Armheim's treatment of simu-
lated data suggests fewer disparities across findings with
greater aggregation of data [19]. Krieger et al., examining
all-cause and selected cause-specific mortality and cancer
incidence rates across Massachusetts and Rhode Island,
found analyses by block group and census tract performed
comparably [20], although tract-level analyses were found
to offer greater linkage to area-based socio-economic indi-
cators [21]. Sheehan et al. reported few differences for
town, zip code or census tract-level analyses of breast can-
cer incidence across Massachusetts, but noted case counts
fluctuated due to various geocoding problems [22].
Here, we address the problem of modifiable areal units
while examining breast and prostate cancer incidence dur-
ing a 5 year interval (1988–92) across Connecticut. Ini-
tially, we utilized geographically referenced data
furnished us by the CT Tumor Registry to consider differ-
ences of incidence and late stage cases according to town
and census tract. Evidence of either global or local cluster-
ing was evaluated using Oden's Ipop [23] and the spatial
scan statistic [24]. Subsequently, we independently ascer-
taining census block group and exact latitude-longitude
coordinates of recorded cases to consider whether greater
precision of location modified/enhanced initial findings.
Results
Prostate cancer incidence
Table 1 displays summary information for results of the
Ipop global clustering test. Examining records aggregated
by town, tract, or block group, the Ipop results indicated
significant non-random clustering of cases throughout the
state. Regardless of the analytic unit considered, approxi-
mately 40% of spatial clustering of prostate cancer inci-
dence is attributed to the comparability of occurrences
'among' adjacent geographic locations, with any remain-
ing clustering attributable to the incidence of cases within
the given geographic units.
Table 2 displays the latitude-longitude coordinates,
approximate size, population at risk, numbers of cases
and ratio of observed-to-expected cases for locations
deemed likely clusters by the spatial scan statistic. Dis-
tances between the geographic coordinates of clusters
identified for block group-level analyses (reference) and
those by town, census tract or individual case coordinates
are noted. The spatial scan statistic identified locales
throughout the State, Depicted in Figure 1, with poten-
tially significant clustering of prostate cancers. Analysis by
block group found four distinct locations with greater
than expected incidence, findings for the tract level analy-
sis identified two places and town level results indicated
one significant site. The most likely locations for each
level of analysis (i.e., primary clusters) depicted as shaded
areas are common to North Central Connecticut (centro-
ids of identified areas differed only by 11.1 km) with
nearly identical ratios of observed-to-expected cases. The
cluster identified at the town level appears more than 4-
times the area of those based on census tracts or block
groups, although it is much more comparable regarding
the respective populations-at-risk (only 20% larger than
others) and numbers of cases (11% difference). Addi-
tional locations where incidence was determined to be
markedly greater than chance (i.e., secondary clusters
depicted empty circles), were found in the southwest
when analyzed by block group and southeast according to
tract-level analysis. There were no significant secondary
clusters based on the town-level analysis.
Breast cancer incidence
Significant global clustering was found at each level of
analysis. According to Ipop test results, the percent of inci-
dent breast cancer cases clustering among geographic
units was somewhat less than that for prostate cancer in
results for town (24.2% vs. 42.6%) or block group (27.9
vs. 40.0%), but similar when examined according to cen-
sus tract (36.3% vs. 39.9%).
The spatial scan statistic applied to block group level data
found two distinct locations, depicted in Figure 2, with
greater than expected breast cancer incidence, findings for
Table 1: Ipop global clustering. Case count correlations for the 
geographic distribution of invasive and late-stage prostate or 
breast cancer incidence within or among selected areal units of 
analysis, Connecticut, 1988–92.
Areal Unit Within % Among % p-value
Prostate Cancer Incidence
Block Group 60.0 40.0 0.0002
Tract 60.1 39.9 0.0002
Town 57.4 42.6 0.0002
Breast Cancer Incidence
Block Group 72.1 27.9 0.0002
Tract 63.7 36.3 0.0002
Town 75.8 24.2 0.0002
Late Stage Prostate Cancer 
Incidence
Block Group 99.7 0.3 0.0008
Tract 87.9 12.1 0.2190
Town 77.0 23.0 0.2740
Late Stage Breast Cancer 
Incidence
Block Group 100.7 -0.7 <0.0001
Tract 100.2 -0.2 0.0002
Town 89.1 10.9 0.0846International Journal of Health Geographics 2005, 4:6 http://www.ij-healthgeographics.com/content/4/1/6
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the tract level analysis found five locations and town level
results indicated two locations of possible clustering.
There was good agreement regarding proximity and extent
of risk between analyses at the block group and tract-level
which identified Southwest Connecticut as the most likely
location for clusters of incident breast cancers. Analysis by
census tract identified a potential cluster with 49% greater
area, 63% more cases and 73% larger population at risk
than results for analysis by bock group. Those findings, by
comparison, differed noticeably from the town-level anal-
ysis that identified the primary incidence cluster as single
Northwestern Connecticut town (88 km from the center
of the most likely cluster identified at the block group
level) with a nearly 6-fold ratio of observed-to-expected
cases. The town-level analysis yielded a secondary cluster
with the locale of primary clusters found by the block
Table 2: Spatial scan statistic clusters. Approximate locations with elevated invasive and late-stage prostate or breast cancer incidence 
according to selected areal units of analysis, Connecticut, 1988–92.
Geocoded 
Records
Coordinates (Lat.; 
Long.)
Area (km2) Population at-risk Cases in 
Cluster
0/E Distance (km) p-value
Prostate Cancer Incidence
Block Group 9,028
1 41.834; -72.727 1,504 254,092 2,651 1.28 Ref. <0.0001
2 41.311; -72.878 0 345 19 7.62 <0.0001
3 41.472; -73.225 0 148 12 6.97 0.0060
4 41.497; -73.218 0 97 13 5.32 0.0316
Tract 9,825
1 41.823; -72.735 1,297 238,007 2,673 1.26 1.4 <0.0001
2 41.463; -72.153 0 1,461 33 3.35 <0.0001
Town 10,054
1 41.995; -72.454 6,104 286,450 2,947 1.22 11.1 <0.0001
Breast Cancer Incidence
Block Group
1 11,753 41.182; -73.510 573 85,084 952 1.22 Ref. 11,753
2 41.797; -72.775 115 27,066 391 1.31 0.0048
Tract 10,924
1 41.137; -73.391 854 147,066 1,554 1.21 11.2 <0.0001
2 41.787; -72.660 0 15 6 162.03 <0.0001
3 41.707; -72.647 87 32,358 401 1.26 0.0228
4 41.795; -72.756 64 20,737 284 1.31 0.0305
5 41.894; -72.368 0 2,137 34 2.34 0.0445
Town 12,518
1 41.960; -73.311 85 402 24 5.85 88.2 <0.0001
2 41.122; -73.346 584 87,795 1,009 1.14 0.0160
Late Stage Prostate Cancer Incidence
Place of Residence 7,672
1 41.486; -73.065 2,057 1,651 549 1.19 2.0 0.0070
2 41.061; -73.458 65 72 41 2.04 0.0135
Block Group 7,672
1 41.501; -73.078 2,218 1,696 563 1.19 Ref. 0.0029
2 41.054; -73.478 44 61 35 2.05 0.0246
Tract 8,346
1 41.480; -73.075 1,895 1,596 541 1.22 2.4 <0.0001
Town 8,514
1 41.489; -73.052 1,959 1,932 644 1.19 2.5 <0.0001
Late Stage Breast Cancer Incidence
Place of Residence 10,227 No significant 
clusters detected
Block Group 10,227 41.666; -72.776 center16 105 center68 1.61 Ref. 0.0092
1
Tract 10,395 No significant 
clusters detected
Town 11,854 No significant 
clusters detectedInternational Journal of Health Geographics 2005, 4:6 http://www.ij-healthgeographics.com/content/4/1/6
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group and tract analyses. The latter analyses, in turn, pro-
duced significant secondary clusters within North Central
Connecticut.
Proportion of late stage prostate cancer
Results of the Ipop statistic for tract and town level analy-
ses did not reveal global clustering of late-stage prostate
cancers, but significant, albeit minimal clustering (i.e.,
only 0.3% of clustering was attributed to cases adjacent
block groups) was indicated in analysis by block group.
The spatial scan statistic using data for exact location of
residence found two locations with proportions of late-
stage cases significantly exceeding the statewide level;
cases aggregated by block group revealed two locations
while tract and town level analyses each produced one sig-
nificant location. Results for primary clusters analyzed
according to block group, tract, town, and exact place of
residence, as illustrated in Figure 3, yielded results with
remarkable comparability regarding approximate
location, affected areas, populations at risk, case counts
and estimated effects.
Proportion of late stage breast cancer
Significant, but slight, global clustering of late stage breast
cancer was found for analyses at the block group and tract
level, but no clustering was found when analyzed accord-
ing to town. According to Figure 4, the spatial scan statistic
was consistent in not locating statistically significant clus-
ters with high proportions of late stage disease when cases
were analyzed according to exact place, census tract or
town of residence. However, analysis by block group
Prostate cancer incidence Figure 1
Prostate cancer incidence. Geographic variation of prostate cancer incidence according to town, census tract and census 
block group units, Connecticut 1988–92. Primary clusters are indicated by solid circles and the statistically significant secondary 
clusters by hollow circles.International Journal of Health Geographics 2005, 4:6 http://www.ij-healthgeographics.com/content/4/1/6
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found one area of Central Connecticut where late stage
cases were 1.61 more likely among diagnosed cases than
elsewhere around the State (p < 0.05).
Discussion
Spatial analysis of health necessarily addresses issues
about the accuracy of geocoded data, the requirements of
time and training necessary to complete tasks, the threats
to protecting confidentiality of sensitive health records
and the interpretability of results for given areal units of
analysis. Desire for greater precision challenges data
safeguards as well as the technical capacity of available
GIS systems. Surveillance by aggregating records into large
areal units will yield greater proportions of accurate and
protected records but possibly at the expense of capacity
to identify discrete locales with elevated rates/proportions
of health outcomes [16].
Our effort to contrast geographic analyses of prostate and
breast cancers according to differing aggregation units
across Connecticut yielded much, but not complete,
consistency across analyses. Like others [20,22], we found
in most instances that results obtained by block group
level data mirrored those based on the census tract. As
such, interpretations based on geocoded data available
through the CTR were not appreciably enhanced by our
further efforts to specify finer levels of geography. Global
clustering of incident prostate and breast cancer cases was
apparent for either level of geography and the test for local
clustering found approximately the same locales, popula-
tions at risk and estimated effects.
On the other hand, some discrepancies were uncovered.
Secondary cluster locations varied by level of analysis.
More importantly, analysis of breast cancer incidence by
Breast cancer incidence Figure 2
Breast cancer incidence. Geographic variation of breast cancer incidence according to town, census tract and census block 
group units, Connecticut 1988–92. Primary clusters are indicated by solid circles and the statistically significant secondary clus-
ters by hollow circles.International Journal of Health Geographics 2005, 4:6 http://www.ij-healthgeographics.com/content/4/1/6
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town yielded an approximate location of a significant pri-
mary cluster some distance from results based on block
group or tract. It is possible that discrepancy is not a
product of analytic scale but the consequence of differing
ability to geocode records across all locales [25]. Test of
this hunch requires analyses whereby cases excluded from
one level of analysis would be excluded from all other
analyses. As our intention was not a pure test of MAUP but
a 'simulation' of the choice investigators might confront
when selecting between a geographically referenced files
in hand (CTR generated) or one independently created
using original address data, we did not pursue this line of
inquiry here.
The local tests for late stage prostate cancer produced sim-
ilar findings of significant clustering for analysis by exact
coordinates, block group, tract or town, whereas results
for the global clustering test were not significant for all but
the block group analysis. Significant global clustering of
late stage breast cancer was found using block group or
tract, but not town or exact coordinates; significant local
clustering was found only for the block group level analy-
sis. Divergence across analyses could reflect distinctions
among the levels of aggregation or merely subtly differ-
ences in the relative size of our data sets. It is noted that
analysis of disaggregate (point) data raise issues separate
from those specific to MAUP which we specifically
address in this paper. It goes without saying that statistical
procedures predicated on disaggregate (point) data would
be unavailable if only aggregate files were available [26].
When analyzing geographic health data, concern regard-
ing scale effects attributable to MAUP is unavoidable.
Increased aggregation of data reduces power to detect very
Late stage prostate cancer incidence Figure 3
Late stage prostate cancer incidence. Geographic variation in proportion of late stage prostate cancer diagnoses accord-
ing to town, census tract, census block group and exact place of residence units, Connecticut, 1988–92. Primary clusters are 
indicated by solid or hatch marked circles and the statistically significant secondary clusters by hollow circles.International Journal of Health Geographics 2005, 4:6 http://www.ij-healthgeographics.com/content/4/1/6
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small clusters but stabilizes rate estimates. For now, the
magnitude and direction of artifact generated by a given
areal unit cannot be reliably predicted. Consequently,
analysts will continue to be driven to select a preferred
areal unit for analysis based on pragmatic rather than
scientific consideration. In the absence of conditions call-
ing for surveillance of small area cancer clusters ('hot
spots'), the rationale for analysts to accept the technical,
political and substantive burdens of preparing data at lev-
els of geography finer than the census tract may not be
compelling. The added protections to personal health
data, the ease of interpretation and the applicability of
similarly structured census and survey data organized
argues for geographic studies to prioritize census tract
level analyses.
Methods
The geographies of breast and prostate cancer incidence in
Connecticut, 1988–1992, were evaluated in relation to
the State's populations-at-risk within towns, census tracts
and block groups for 1990 (1,160,886 males, and
1,282,917 females 20+ years of age according to seven
age-categories: 20–29 years, 30–39, 40–49, 50–59, 60–
69, 70–79, 80+) [27]. The at-risk populations are predom-
inantly white (89.1%) and concentrated along Connecti-
cut's southern shoreline and central river valley; eastern
and northwestern sections of the State are considerably
less densely populated. As shown in Table 3, Connecti-
cut's population is spatially organized within its 12,550
square mile area according to, 169 municipalities
(towns), 834 census tracts and 2,905 block groups, as well
as 50,569 census blocks, 330 zip codes, eight counties and
two telephone area codes.
Between 1988 and 1992, the Connecticut Tumor Registry
(CTR) recorded incidence and stage of diagnosis of
10,054 invasive cancers of the prostate (ICD-9-185) and
12,518 breast cancers (ICD-9-174) among State residents.
Late stage breast cancer incidence Figure 4
Late stage breast cancer incidence. Geographic variation in proportion of late stage breast cancer diagnoses according to 
town, census tract, census block group and exact place of residence units, Connecticut, 1988–92.International Journal of Health Geographics 2005, 4:6 http://www.ij-healthgeographics.com/content/4/1/6
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The Institutional Review Boards of the University of
Connecticut and Connecticut State Department of Public
Health approved our access to, and analysis of informa-
tion reported here.
Geographic analyses of incidence by town and census
tract were based on geographically referenced data files
provided to us by the CTR. Every record identified an indi-
vidual's town of residence and most assigned a census
tract of residence to records (98% of prostate and 87% of
breast cancer records). Total case counts are presented in
Table 4. Why some records were not assigned census tract
identifiers by the CTR could not be determined here.
To examine if geographic patterns of cancer incidence and
late stage change at finer units of analysis, we subse-
quently used the full street address available within the
CTR record to independently assigned latitude-longitude
coordinates to census block group and place of residence
for 9,207 prostate (92%) and 11,864 breast (95%) cancer
records. Our purpose was neither to augment nor correct
the CTR data, but to generate separate geographically-ref-
erenced files to study cancer patterns according to aggre-
gation units otherwise unavailable to external researchers.
This accounts for the seemingly incongruous observation
that 11,753 records were geocoded (by us) to block group
whereas only 10,924 records were geocoded (by CTR) to
tract. The result of our effort, vis-à-vis data provided by the
CTR, is summarized in Table 4. As there is no 'gold stand-
ard' available to validate geocoded results, no effort was
made to enumerate or resolve ambiguities that could be
noted if files were directly compared.
Approximately one-half of records geocoded in this man-
ner were categorized using stringent coding criteria (i.e.,
an address conforms completely to a street location recog-
nized by geocoding software); the remainder were com-
pleted using 'relaxed' procedures (i.e., an address bearing
one or more incongruities was assigned to the 'most likely'
street location by the geocoding software) [28]. We were
unable to geocode 847 prostate and 654 breast cancer
records because only a Post Office box was available, no
street or house number was recorded or the recorded
address could not be matched to a recognized street loca-
Table 3: Spatial and population characteristics of selected areal units of Connecticut.
Unit Places Area (sq. km) 1990 Population 20 & Over Persons 20 + years per sq. 
mile
State 1 12,550 2,443,803 195
County 8 956 to 2,383 72,931 to 635,829 54 to 382
Town 169 13 to 160 443 to 100,552 6 to 2,426
Zip code 263 0.5 to 249 19 to 45,623 9 to 3,943
Census tract 834 <0.01 to 160 0 to 7,507 6 to 9,077
Block group 2,905 <0.01 to 86 0 to 5,415 0 to 21,333
Census block 50,569 Not available 0 to 2,796 Not available
Table 4: Geocoding of incident prostate and breast cancer cases, Connecticut, 1988–92.
Prostate Cancers Breast Cancers
Cases % Cases %
Incident cases with town of residence recorded by the Connecticut Tumor Registry 
(CTR)
10,054 100 12,518 100
Census tract of residence recorded by CTR 9,825 98 10,924 87
Geocoded block group & street address of residence 9,207 92 11,864 95
Geocoded street address on 1st try (stringent criteria) 4,546 5,926
Geocoded street address on 2nd try (relaxed criteria) 4,661 5,938
Nursing home resident excluded for analysis by block group and exact coordinates 179 111
Record not geocoded 847 8 654 5
Post Office box listed 178 64
No street address listed 216 534
No house number listed 176 23
Listed address unable to geocode 277 33International Journal of Health Geographics 2005, 4:6 http://www.ij-healthgeographics.com/content/4/1/6
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tion. Records for individuals with addresses associated
with nursing home were not included in this phase of
analysis (179 prostate and 111 breast cancer records,
respectively); leaving totals of 9,028 prostate cancers and
11,753 breast cancers for study.
Numerous tests for spatial randomness (i.e., are geograph-
ical patterns due to random fluctuations/chance or true
underlying variability?) are available [29]. For purposes of
illustration, we selected one global clustering and one clus-
ter detection test to evaluate geographic variations of dis-
ease rates.
Oden's Ipop [23] indicates whether there is an overall pat-
tern of spatial aggregation of cases throughout the study
region, without regard to specific locations where
aggregation might occur. Group data are used to generate
a weighted correlation coefficient, adjusted for popula-
tion size, that indicates the extent to which case counts
within given locations are associated with values of neigh-
boring locales (i.e., are places with high frequencies adja-
cent to places with similarly high frequencies?). The
significance of the computed value is evaluated in relation
to an expectation derived by a hypothetical null spatial
distribution of data. Oden's Ipop was calculated using
ClusterSeer v2.06 software [30].
The spatial scan statistic [24] looks for significant concen-
tration of cases at specific locations within a study region
without preconceptions about where concentrations
might be found. The spatial scan statistic utilizes scanning
circles of varying location and size so as to contain 0–25%
of the State's population at risk to identify places where
the number of observed cases exceeds expectation under a
null hypothesis that incidence is proportional to popula-
tion density. The spatial scan statistic was calculated using
SaTScan 3.1 [31].
Among the available address matched records, 9,207
(92%) prostate cancer and 11,864 (95%) breast cancer
records contained sufficient information for geographic
analyses of 'late stage' disease across the State. Historical
SEER summary stage classifications [32] were used where
regional/distant prostate or breast cancers were noted
among 2,198 (28%) and 4,119 (40%) records, respec-
tively. Analyses of geographic distribution of disease stage
(regional/ distant versus local) using Oden's Ipop and the
spatial scan statistic were completed according to town,
census tract and census block group of residence. The spa-
tial scan also was applied using exact place of residence
coordinates of cases; because necessary group boundaries
for discrete residential locations are unavailable, Oden's
Ipop could not be used with individual coordinates. Map-
titude 4.5 software [28] was used to map cluster locations
with markedly high incidence rates (Figures 1 and 2) or
proportions of late-stage disease (Figures 3 and 4).
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